Biomarker Validation
Featured Protocols
Cancer Biomarkers
.
Vendor-submitted protocol
.
Sponsored by
Origene Technologies
.
Published in
November
2007
Latest Protocols
Vendor-submitted protocol.
Sponsored by
PerkinElmer
Published in
November
2009
The AlphaLISA® homogenous (i.e., no-wash) immunoassay platform employs a very simple assay protocol that is much faster than a traditional ELISA assay. When compared to competing TR-FRET homogeneous assays, AlphaLISA biomarker assays provide superior performance in terms of sensitivity, dynamic range, and variability.
Cancer Biomarkers
Vendor-submitted protocol.
Sponsored by
Origene Technologies
Published in
BioTechniques Protocol Guide 2009
TissueScan is a unique qPCR array for fast and accurate gene expression profiling across a large number of cancer patient samples. High-quality cDNAs were prepared from thousands of well-documented cancer biopsy samples, normalized, and assembled into ready-to-use gene expression panels.
Cancer Biomarkers
Vendor-submitted protocol.
Sponsored by
Origene Technologies
Published in
November
2007
TissueScan is a unique qPCR array of first-strand cDNA from hundreds of clinical tumor samples. It provides a fast and accurate gene expression profiling across a large number of cancer patient samples.
Cancer Biomarkers
Vendor-submitted protocol.
Published in
December 2006
2007
TissueScan is a unique RT-PCR based system for fast and accurate gene expression profiling across a large number of cancer patient samples. High-quality cDNAs were prepared from 48 well-documented cancer biopsy samples, normalized and assembled into ready-to-use gene expression panels.
rightcontent.jsp called otherwise condition
rightcontent.jsp called
11111111111111111111
[]
Sub-categories
Cancer Biomarkers
Search Protocols
Search our protocols for your specific technique.
Submit Your Protocols
BioTechniques is always looking for author-submitted protocols related to peer-reviewed papers, so submit your protocols today to our editorial team. Suppliers or advertisers interested in publishing their protocols should also submit.
Click here for more information
Click here for more information
Categories